These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 37824465

  • 21. Clinical significance of serum soluble TNF receptor II level and soluble TNF receptor II/I ratio as indicators of coronary artery lesion development in Kawasaki disease.
    Shimizu M, Mizuta M, Usami M, Inoue N, Sakakibara Y, Yamada K, Konishi M, Ohta K, Yachie A.
    Cytokine; 2018 Aug; 108():168-172. PubMed ID: 29625336
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

  • 23. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A, Pal P, Basu S.
    Rheumatol Int; 2019 Oct; 39(10):1797-1801. PubMed ID: 31302740
    [Abstract] [Full Text] [Related]

  • 24. Association between adropin and coronary artery lesions in children with Kawasaki disease.
    Yang M, Pei Q, Zhang J, Weng H, Jing F, Yi Q.
    Eur J Pediatr; 2021 Jul; 180(7):2253-2259. PubMed ID: 33712900
    [Abstract] [Full Text] [Related]

  • 25. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J, Jiang H, Lu M.
    Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395
    [Abstract] [Full Text] [Related]

  • 26. Serum proteins may facilitate the identification of Kawasaki disease and promote in vitro neutrophil infiltration.
    Li SC, Tsai KW, Huang LH, Weng KP, Chien KJ, Lin Y, Tu CY, Lin PH.
    Sci Rep; 2020 Sep 24; 10(1):15645. PubMed ID: 32973234
    [Abstract] [Full Text] [Related]

  • 27. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED.
    Pediatr Cardiol; 2003 Sep 24; 24(2):122-6. PubMed ID: 12457252
    [Abstract] [Full Text] [Related]

  • 28. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
    Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
    Turk J Pediatr; 2020 Sep 24; 62(1):1-9. PubMed ID: 32253860
    [Abstract] [Full Text] [Related]

  • 29. Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease.
    Zhao CN, Du ZD, Gao LL.
    Chin Med J (Engl); 2016 Apr 20; 129(8):922-8. PubMed ID: 27064036
    [Abstract] [Full Text] [Related]

  • 30. Albumin level and progression of coronary artery lesions in Kawasaki disease: A retrospective cohort study.
    Xia Y, Qiu H, Wen Z, Shi H, Yu H, Li J, Zhang Q, Wang J, Rong X, Wu R, Chu M.
    Front Pediatr; 2022 Apr 20; 10():947059. PubMed ID: 36186633
    [Abstract] [Full Text] [Related]

  • 31. Development of a prediction model for progression of coronary artery lesions in Kawasaki disease.
    Xu D, Chen YS, Feng CH, Cao AM, Li XH.
    Pediatr Res; 2024 Mar 20; 95(4):1041-1050. PubMed ID: 38040988
    [Abstract] [Full Text] [Related]

  • 32. The expression of autophagy markers in IVIG-resistant Kawasaki disease and the establishment of prediction model.
    Zhou Y, Wu Y, Yuan C, Yin W, Wang B, Ding Y.
    BMC Pediatr; 2023 Dec 19; 23(1):642. PubMed ID: 38114939
    [Abstract] [Full Text] [Related]

  • 33. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
    Clin Exp Med; 2022 Nov 19; 22(4):621-628. PubMed ID: 35039938
    [Abstract] [Full Text] [Related]

  • 34. Increased concentrations of growth differentiation factor-15 in children with Kawasaki disease.
    Li G, Wang T, Li J, Chen P, Jia P, Zhao J, Duan Y, Liu D, Xu X, Liu B.
    Clin Chim Acta; 2020 Aug 19; 507():264-270. PubMed ID: 32387635
    [Abstract] [Full Text] [Related]

  • 35. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
    Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.
    Kaohsiung J Med Sci; 2012 Jan 19; 28(1):23-9. PubMed ID: 22226058
    [Abstract] [Full Text] [Related]

  • 36. [Clinical features of Kawasaki disease complicated by macrophage activation syndrome: an analysis of 27 cases].
    Wen YN, Chen J, Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jun 15; 25(6):572-578. PubMed ID: 37382125
    [Abstract] [Full Text] [Related]

  • 37. Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease.
    Masuda H, Ae R, Koshimizu TA, Matsumura M, Kosami K, Hayashida K, Makino N, Matsubara Y, Sasahara T, Nakamura Y.
    Clin Rheumatol; 2022 Jan 15; 41(1):137-145. PubMed ID: 34363547
    [Abstract] [Full Text] [Related]

  • 38. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
    [Abstract] [Full Text] [Related]

  • 39. Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.
    Giannouli G, Tzoumaka-Bakoula C, Kopsidas I, Papadogeorgou P, Chrousos GP, Michos A.
    Pediatr Cardiol; 2013 Aug 27; 34(6):1476-81. PubMed ID: 23463134
    [Abstract] [Full Text] [Related]

  • 40. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
    Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
    Clin Drug Investig; 2011 Aug 27; 31(3):191-9. PubMed ID: 21456105
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.